Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists (SABAs), Long-acting Beta-Agonists (LABAs), Long-acting Muscarinic Antagonists (LAMAs), Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs
The global asthma & COPD therapies market was valued at $32.9bn in 2016 and is projected to grow at a CAGR of 5.6% in the first half of the forecast period. The Anti-inflammatory Drugs submarket will be the fastest growing submarket in the first half of the forecast period. This submarket is estimated to grow at a CAGR of 7.6%.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you:
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 300-page report you will receive 113 tables and 130 figures - all unavailable elsewhere.
The 300-page report provides clear detailed insight into the global asthma & COPD therapies market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope:
• Global Asthma & COPD Therapies Market forecasts from 2017-2027, further broken down into:
- Global Asthma Therapies Market forecasts
- Global COPD Therapies Market forecasts
• Revenue forecasts of the three main drug classes of the global asthma & COPD therapies market:
- Bronchodilators monotherapy
- Anti-inflammatory drugs
- Combination drugs
• Revenue forecast for the Bronchodilators monotherapy market by Type and revenue forecast of the leading drugs:
- Short-acting beta2-agonists (SABAs): Ventolin, ProAir, Proventil, Xopenex
- Long-acting beta2-agonists (LABAs): Brovana, Foradil, Arcapta/Onbrez, Serevent,
- Anticholinergics: Spiriva, Atrovent, Eklira/Tudorza/Bretaris
• Revenue forecast for the Anti-inflammatory drugs market by Type and revenue forecast of the leading drugs:
- Corticosteroids: Pulmicort, Flixotide/Flovent, QVAR, Asmanex
- Anti-leukotrienes: Singulair
- Monoclonal antibodies (mAbs): Xolair, Cinquil/Cinquair, Nucala, Benralizumab, Lebrikizumab, Dupilumab
• Revenue forecast for the Combination drugs market and the leading drugs:
- Advair/Seretide, Symbicort, Combivent, Dulera, Relvar/Breo
• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
- The US
- Japan
- EU5: Germany, France, UK, Italy, Spain
- BRIC: Brazil, Russia, India, China
- Mexico
- Other Countries
• This report discusses the leading companies in the global asthma & COPD therapies market:
- GSK
- Boehringer Ingelheim
- AstraZeneca
- Novartis
- Merck
- Roche
- Teva
• This report discusses drugs currently in clinical development for treating asthma and COPD.
• This report discusses the SWOT analysis as well as porter's five forces analysis of the global asthma & COPD therapies market.
Visiongain's study is intended for anyone requiring commercial analyses for the global asthma & COPD therapies market. You find data, trends and predictions.
Buy our report today Global Asthma & COPD Therapies Market 2017-2027:
Bronchodilator Monotherapy, Anticholinergics, Short-acting Beta-Agonists (SABAs), Long-acting Beta-Agonists (LABAs), Long-acting Muscarinic Antagonists (LAMAs), Anti-Inflammatory Drugs, Corticosteroids, Anti-Leukotrienes, Monoclonal Antibodies, Combination Drugs.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100.
Or click on https://www.visiongain.com/Report/1988/Global-Asthma-COPD-Therapies-Market-2017-2027
Companies Mentioned in the Report
3M Drug Delivery Systems
AB Science
Actavis
Alcon
Alembic
Allen and Hanburys
Allergan
Almirall
Apotex
Ario Pharma
Array BioPharma
Aspen Pharmacare
Astellas Pharma
AstraZeneca
Aurobindo Pharma
Bellephron
Ben Vue Laboratories
BioWa
BioXpress Therapeutics
Boehringer Ingelheim
Breath Limited
Bristol-Meyer Squibbs
Catalent Pharma Solutions
Cephalon
Ception Therapeutics
Chiesi Pharmaceuticals
Ciba-Geigy
Cipla
Circassia Pharmaceuticals
CVS Caremark
Daewoong Pharmaceutical
Dainippon Sumimoto
Dr. Reddy's Laboratories
Express Scripts
Forest Pharmaceuticals
Fountain Biopharma
Genentech (Roche)
Grifols
GSK
Hikma Pharmaceuticals
Ikaria
Invion
Kamada
Kyorin Pharmaceuticals
Kyowa Hakko Kirin
Lilly
Mariposa
MedicNova
Medimmune
Menarini
Merck & Co.
Mylan
Novartis
Nycomed
Omega Pharma
Orion Pharmaceuticals
Pearl Therapeutics
Perrigo
Pfizer
Prosonix
Reckitt Becnkiser
Regeneron
Roche
Roxane Laboratories
Sandoz (Novaris)
Sanofi
Schering-Plough's
SkyePharma
Sofotec
Stempeutics
Sunovion Pharmaceuticals
Synairgen
Takeda Pharmaceuticals
Tanox
Teva
Theravance
Vectura
Viatris
Watson (Actavis)
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
